E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) is Buildings and Property in United States that focus on sale license business. They cover business area such as drug, medication, aerosol form, use, meter-dose inhaler, treatment, asthma.
-
Sale License
-
1007 Market Street
Wilmington, DE 19898
United States
Private
drugmedicationaerosol formusemeter-dose inhalertreatmentasthma
* We use standard office opening hours in near E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
E. I. Du Pont De Nemours (License For Pharmaceutical Grade HFC-227ea/P Product) is Buildings and Property business from United States that founded in - ( years old in ), E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) business is focusing on Sale License.
E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) headquarter office and corporate office address is located in 1007 Market Street Wilmington, DE 19898 United States.
E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) was founded in United States.
In , E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product) is currently focus on sale license sector.
Above is snippet of Google Trends for "sale license" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with E. I. du Pont de Nemours (License for Pharmaceutical Grade HFC-227ea/P Product), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
